Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19
NCT05164120
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Belnacasan
DRUG:
Placebo
Sponsor
MedStar Health